Clinical Trial Update: Understanding Hemophilia A and B Drug Dosage Administration Patterns

View source ↗

Summary

Clinical trial update on dosage administration patterns for Hemophilia A and B; study is terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Pfizer | Conditions: Hemophilia A, Hemophilia B | Status: TERMINATED | Results posted: 2019-05-20